Identification and control of a degradation product in Avapro film-coated tablet: low dose formulation.
A degradation product was formed during the long-term stability studies (LTSS) of the low dose formulation of Avapro film-coated tablet. The degradant was identified as the hydroxymethyl derivative (formaldehyde adduct) of the drug substance, irbesartan, based upon analysis with LC/MS, LC/MS/MS, and chromatographic comparison to the synthetic hydroxymethyl degradation product. Laboratory studies demonstrated that the interaction of individual excipients with the drug substance at elevated temperature and polyethylene glycol (PEG) used in the coating material, Opadry II White, leads to the generation of this formaldehyde adduct. Spiking of formaldehyde to the solution of drug substance gradually produced this impurity and the kinetics studies demonstrated that the reaction between formaldehyde and irbesartan is a second order reaction with a rate constant of 2.6 x 10(-4) M(-1)min(-1) at 25 degrees C in an aqueous media. The redevelopment of the formulation by eliminating PEG from the Opadry II White dry-blend system was enabled by understanding the formaldehyde adduct formation.
Wang
George
G
Analytical Research and Development, Research and Development, Bristol-Myers Squibb, New Brunswick, New Jersey, USA.
Fiske
John D
JD
Jennings
Scott P
SP
Tomasella
Frank P
FP
Palaniswamy
Venkatapuram A
VA
Ray
Kenneth L
KL
D047228:Angiotensin II Type 1 Receptor Blockers / Q000032:analysis / Q000737:chemistry*; D001713:Biphenyl Compounds / Q000032:analysis / Q000737:chemistry*; D002853:Chromatography, Liquid; D004344:Drug Incompatibility; D004355:Drug Stability; D004356:Drug Storage; D005079:Excipients / Q000737:chemistry; D005557:Formaldehyde / Q000737:chemistry*; D000077405:Irbesartan; D011092:Polyethylene Glycols / Q000737:chemistry; D013607:Tablets; D053719:Tandem Mass Spectrometry; D013696:Temperature; D013777:Tetrazoles / Q000032:analysis / Q000737:chemistry*
D047228:Angiotensin II Type 1 Receptor Blockers; D001713:Biphenyl Compounds; D005079:Excipients; D013607:Tablets; D013777:Tetrazoles; D005557:Formaldehyde; D011092:Polyethylene Glycols; D000077405:Irbesartan